Effect of Dupilumab (anti-IL4R?) on the Host-Microbe Interface in Atopic Dermatitis Abstract: Atopic Dermatitis (AD) is the most common inflammatory skin disease, affecting 15 million Americans (up to 17% of children and 10% adults) with the most severe disease typically observed in adult patients. It is characterized by a Th2 immune response directed against airborne, food and S. aureus antigens, a leaky epithelial barrier and a susceptibility to cutaneous colonization with S. aureus. Which of these features is primary and which are secondary remains unclear. To begin to address this critical question we have proposed an interventional human clinical trial with dupilumab (anti-IL4R?), a highly effective biologic that blocks the binding of the canonical Th2 cytokines, IL-4 and IL-13 to their relevant receptors. This will be a multicenter, RDBPC in adult patients with moderate-severe AD ( skin colonization with S. aureus). We will stratify enrollment with equal numbers of AD subjects with and without S. aureus colonization to address whether these subphenotypes differ at baseline or in response to Th2 blockade. Our central hypothesis is that dupilumab treatment will normalize the cutaneous dysbiosis, epidermal biology and cutaneous immune responses in AD subjects. We predict that AD subjects colonized with S. aureus will have more severe defects in skin barrier, innate immunity, reduced responses to intradermal vaccination and will be more responsive to dupilumab treatment. These hypotheses are a natural evolution of ADRN observations made over the past 5- 10 years. Specifically, this study will 1) identify how dupilumab alters the baseline interactions between the epidermal transcriptome, epidermal lipidomics, microbiome & microbial transcriptome, immunoprofile of circulating leukocytes and what role S. aureus colonization plays in these networks, 2) characterize the effect of dupilumab on skin barrier function and the epidermal innate immune system, 3) evaluate the effect of dupilumab on the adaptive immune response to cutaneous vaccination. In summary, this is a mechanistic study that is highly responsive to the RFP as it utilizes a novel and safe systemic therapeutic agent to selectively target highly relevant cytokines in two AD subphenotypes and in so doing will determine whether Th2 cytokines affect skin microbiota, barrier, and vaccine responsiveness utilizing state-of-the-art technologies with an exciting group of talented and collaborative investigators who are leaders in their field.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Research Program--Cooperative Agreements (U19)
Project #
Application #
Study Section
Special Emphasis Panel (ZAI1-ZL-I)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
National Jewish Health
Independent Hospitals
United States
Zip Code
Simpson, Eric L; Villarreal, Miguel; Jepson, Brett et al. (2018) Patients with Atopic Dermatitis Colonized with Staphylococcus aureus Have a Distinct Phenotype and Endotype. J Invest Dermatol 138:2224-2233
O'Neill, Alan M; Gallo, Richard L (2018) Host-microbiome interactions and recent progress into understanding the biology of acne vulgaris. Microbiome 6:177
Berdyshev, Evgeny; Goleva, Elena; Bronova, Irina et al. (2018) Lipid abnormalities in atopic skin are driven by type 2 cytokines. JCI Insight 3:
Shi, Baochen; Leung, Donald Y M; Taylor, Patricia A et al. (2018) Methicillin-Resistant Staphylococcus aureus Colonization Is Associated with Decreased Skin Commensal Bacteria in Atopic Dermatitis. J Invest Dermatol 138:1668-1671
Li, Jin; Zheng, Le; Uchiyama, Akihiko et al. (2018) A data mining paradigm for identifying key factors in biological processes using gene expression data. Sci Rep 8:9083
Malhotra, Nidhi; Leyva-Castillo, Juan Manuel; Jadhav, Unmesh et al. (2018) ROR?-expressing T regulatory cells restrain allergic skin inflammation. Sci Immunol 3:
Bin, Lianghua; Li, Xiaozhao; Richers, Brittany et al. (2018) Ankyrin repeat domain 1 regulates innate immune responses against herpes simplex virus 1: A potential role in eczema herpeticum. J Allergy Clin Immunol 141:2085-2093.e1
Dyjack, Nathan; Goleva, Elena; Rios, Cydney et al. (2018) Minimally invasive skin tape strip RNA sequencing identifies novel characteristics of the type 2-high atopic dermatitis disease endotype. J Allergy Clin Immunol 141:1298-1309
Archer, Nathan K; Jo, Jay-Hyun; Lee, Steven K et al. (2018) Injury, dysbiosis, and filaggrin deficiency drive skin inflammation through keratinocyte IL-1? release. J Allergy Clin Immunol :
Leyva-Castillo, Juan Manuel; Yoon, Juhan; Geha, Raif S (2018) IL-22 promotes allergic airway inflammation in epicutaneously sensitized mice. J Allergy Clin Immunol :

Showing the most recent 10 out of 41 publications